- Home
- GLP vs CLDX Comparison
GLP vs CLDX Comparison
Compare GLP & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLP
- CLDX
- Stock Information
- Founded
- GLP 2005
- CLDX 1983
- Country
- GLP United States
- CLDX United States
- Employees
- GLP N/A
- CLDX N/A
- Industry
- GLP Oil Refining/Marketing
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- GLP Energy
- CLDX Health Care
- Exchange
- GLP Nasdaq
- CLDX Nasdaq
- Market Cap
- GLP 1.8B
- CLDX 1.6B
- IPO Year
- GLP 2005
- CLDX 2008
- Fundamental
- Price
- GLP $52.57
- CLDX $23.78
- Analyst Decision
- GLP Strong Buy
- CLDX Buy
- Analyst Count
- GLP 1
- CLDX 7
- Target Price
- GLP $54.00
- CLDX $64.83
- AVG Volume (30 Days)
- GLP 73.7K
- CLDX 1.1M
- Earning Date
- GLP 02-26-2025
- CLDX 02-24-2025
- Dividend Yield
- GLP 5.52%
- CLDX N/A
- EPS Growth
- GLP N/A
- CLDX N/A
- EPS
- GLP 3.31
- CLDX N/A
- Revenue
- GLP $17,386,440,000.00
- CLDX $9,976,000.00
- Revenue This Year
- GLP $15.01
- CLDX N/A
- Revenue Next Year
- GLP $30.51
- CLDX N/A
- P/E Ratio
- GLP $15.99
- CLDX N/A
- Revenue Growth
- GLP 5.31
- CLDX 128.55
- 52 Week Low
- GLP $37.00
- CLDX $22.17
- 52 Week High
- GLP $58.77
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- GLP 61.60
- CLDX 41.99
- Support Level
- GLP $48.80
- CLDX $22.17
- Resistance Level
- GLP $48.66
- CLDX $29.05
- Average True Range (ATR)
- GLP 2.09
- CLDX 1.57
- MACD
- GLP 0.72
- CLDX -0.26
- Stochastic Oscillator
- GLP 89.01
- CLDX 23.40
About GLP Global Partners LP Common Units representing Limited Partner Interests
Global Partners LP is an U.S.-based limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the Wholesale segment.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.